Atlas Trials

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

Clinical trial NCT00511992 · COMPLETED

Trial details

NCT number
NCT00511992
Sponsor
University of Oklahoma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Ovarian CarcinomaPrimary Peritoneal CarcinomaOvarian Carcinosarcoma
Start date
2007-07-01
Primary completion
2015-08-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.